You can view the research column published every month by SMC Laboratories.
2025.02.02
One of our clients published preclinical data on NASH-fibrosis on Cellular and Molecular Gastroenterology and Hepatology
We announced that the results of the study in the STAM™ mouse model of NASH has been published in Cellular and…
READ MORE
2025.02.02
One of our clients published preclinical data on NASH-fibrosis on Glycoconjugate Journal
We announced that a study in the STAM™ mouse model of NASH performed by SMC Laboratories Inc. has been publish…
READ MORE
2025.02.02
One of our clients published preclinical data on NASH-fibrosis on Liver Cancer
We announced that a study in the STAM™ mouse model of NASH performed by SMC Laboratories Inc. has been publish…
READ MORE
2025.02.02
One of our clients published preclinical data on NASH-fibrosis on PLoS One
We announced that a study in the STAM mouse model of NASH performed by SMC Laboratories Inc. has been publishe…
READ MORE
2025.02.02
One of our clients published preclinical data on the FASEB Journa
One of our clients FDA-National Center for Toxicological Research (NCTR) has published the results of a study …
READ MORE
2025.02.02
One of our clients published preclinical data on NASH on Oncotarget
One of our clients Kanazawa University has published the results of a study using STAMTM model on Oncotarget. …
READ MORE
2025.02.02
Our clients published preclinical data on NASH on Molecular Cancer Research
One of our clients FDA-National Center for Toxicological Research (NCTR) has published the results of a study …
READ MORE
2025.02.02
Our clients published preclinical data on NASH-HCC on Oncotarget
One of our clients FDA-National Center for Toxicological Research (NCTR) has published the results of a study …
READ MORE
2025.02.02
Client Publication Announcement / European Radiology Experimental
We would like to introduce an update regarding a new article published by our client in European Radiology Exp…
READ MORE
2025.02.02
Experience in Evaluating Drug Efficacy in a Bleomycin-Induced IPF Model
Today, we would like to introduce the modalities and target molecules that we have experience in evaluating dr…
READ MORE
